Commentary|Articles|June 24, 2025

Modern Retina Digital Edition

  • Modern Retina May and June 2025
  • Volume 5
  • Issue 2

Pearls for engaging in clinical trials

Make the most of your practice and your retina conference participation.

One of my favorite components of my career has been building a leading clinical trial program at our practice. Clinical science has allowed me to offer cutting-edge treatments in my community while providing a clear path to remain engaged internationally in retina and move our field forward. Clinical science has also served as a growth engine and energizer to our practice, which has doubled in size since I joined in 2007.

Many colleagues at all stages of their careers often speak with me about their interest in starting or expanding their own clinical trial programs. My primary advice is that there is no substitute for the engaged principal investigator (PI). All great clinical trial programs start with a positive and hard-working MD leader, both able and excited to put in the extra hours outside of patient care to develop the program.

Three pearls help these engaged PIs lead:

  1. Say “Yes!” when opportunities arise. Do everything you can, especially when a program is new or trying to flourish.
  2. Be fun and rewarding to work with. Everyone likes to collaborate with a can-do attitude.
  3. Go to scientific meetings. It is important to be visible and connect with people in person. Virtual connections are great once you know someone, but there is no substitute for live interaction.

Robert Collier said, “success is the sum of small efforts, repeated day in and day out.” So, as we approach the busiest retina meeting season, remember each small effort and give these pearls a try. You will be impressed with how they differentiate you, invite opportunity, and give you the chance to develop your clinical trial site.

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.


Latest CME